Dose response of repaglinide in patients with newly diagnosed type 2 diabetes: Effect on B-cell secretion

被引：0
|
作者：
Dunseath, GJ
Luzio, SD
Cozma, L
Owens, DR
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
391
引用
收藏
页码：A96 / A96
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF CHRONIC HYPERGLYCEMIA ON THE ISLET B-CELL RESPONSIVENESS IN NEWLY DIAGNOSED TYPE-2 DIABETES
    GJESSING, HJ
    REINHOLD, B
    PEDERSEN, O
    DIABETIC MEDICINE, 1992, 9 (07) : 601 - 604
  • [2] Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
    Wang, Liang-Chen
    Fang, Fu-Sheng
    Gong, Yan-Ping
    Yang, Guang
    Li, Chun-Lin
    MEDICINE, 2018, 97 (38)
  • [3] Effect of Baseline β-Cell Function on Treatment Response to Exenatide in Patients with Newly Diagnosed Type 2 Diabetes
    Wang, Chaofan
    Xu, Wen
    Deng, Hongrong
    Lin, Beisi
    Lv, Jing
    Zeng, Longyi
    Yao, Bin
    Weng, Jianping
    DIABETES, 2020, 69
  • [4] Effects of treatment with repaglinide or gliclazide on glucose control and early-phase insulin secretion in patients with newly diagnosed type 2 diabetes
    Zhang, H.
    Bu, P.
    Lei, M.
    Mo, Z.
    Liao, E.
    DIABETOLOGIA, 2008, 51 : S375 - S376
  • [5] Decreased b-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes
    Xubin Yang
    Wen Xu
    Yanhua Zhu
    Hongrong Deng
    Ying Tan
    Longyi Zeng
    Jianping Weng
    NeuroscienceBulletin, 2019, 35 (01) : 25 - 33
  • [6] Comparison of repaglinide and metformin monotherapy as an initial therapy in Chinese patients with newly diagnosed type 2 diabetes mellitus
    Fang, Fu-Sheng
    Gong, Yan-Ping
    Li, Chun-Lin
    Li, Jian
    Tian, Hui
    Huang, Wei
    Wang, Liang-Chen
    Li, Lin
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (06) : 901 - 908
  • [7] The impaired acute insulin response in newly diagnosed Type 2 diabetic patients can be restored by nateglinide and repaglinide
    Wang, FN
    Liao, ZH
    Yao, B
    Li, YB
    Hu, GL
    Weng, JP
    DIABETOLOGIA, 2004, 47 : A254 - A254
  • [8] Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes
    Kolendorf, K
    Eriksson, J
    Birkeland, KI
    Kjellström, T
    Hreidarsson, AB
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (01) : 33 - 40
  • [9] B-CELL SUBPOPULATIONS IN NEWLY DIAGNOSED EORA AND YORA PATIENTS
    Thorarinsdottir, K.
    Camponeschi, A.
    Jacobsson, L.
    Martensson, I. -L.
    Gjertsson, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1217 - 1217
  • [10] Association of a SLC30A8 Genetic Variant with Monotherapy of Repaglinide and Rosiglitazone Effect in Newly Diagnosed Type 2 Diabetes Patients in China
    JIANG Feng 1
    Biomedical and Environmental Sciences, 2012, 25 (01) : 23 - 29
12345